Showing results (61-70 of 760) with videos related to

Sort By:
Pageof 76
European Journal of Clinical Investigation|September 27, 2014
Prognostic role of Twist or Snail in various carcinomas: a systematic review and meta-analysisPing Zhang, Pingping Hu, Hongchang Shen, et al.
The International Journal of Biochemistry & Cell Biology|January 13, 2015
PKD1 is downregulated in non-small cell lung cancer and mediates the feedback inhibition of mTORC1-S6K1 axis in response to phorbol esterYang Ni, Liguang Wang, Jihong Zhang, et al.
Clinical Lung Cancer|August 6, 2013
Response to first-line chemotherapy in patients with non-small-cell lung cancer according to epidermal growth factor receptor and K-RAS mutation statusXiaopeng Dong, Xiaogang Zhao, Yingtao Hao, et al.
Plos One|March 21, 2014
Response to first-line chemotherapy in patients with non-small cell lung cancer according to RRM1 expressionXiaopeng Dong, Yingtao Hao, Yucheng Wei, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 14, 2025
Multi-omics integrative analysis elucidates the molecular characteristics of SMARCA4-deficient lung adenocarcinoma and the derived therapeutic optionsDeyu Guo, Kai Wang, Shijie Sun, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 8, 2015
Combination of DC Vaccine and Conventional ChemotherapeuticsWei Dong, Ran Wei, Hongchang Shen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 10, 2014
Tumor-infiltrating neutrophils predict poor outcome in adenocarcinoma of the esophagogastric junctionPingping Hu, Zhaofei Pang, Hongchang Shen, et al.
Medicine|May 18, 2019
Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodesHongfeng Liu, Tao Yan, Tiehong Zhang, et al.
Chemical Science|July 13, 2018
Conjugated polymer-enhanced enantioselectivity in fluorescent sensingXuepeng Zhang, Chao Wang, Pan Wang, et al.
Scientific Reports|November 1, 2014
Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinomaTiehong Zhang, Hongchang Shen, Wei Dong, et al.
Pageof 76